Why a Diabetes Drug Fell Short of Anticancer Hopes ...Middle East

Medscape - News
Metformin, commonly used to treat diabetes, has been investigated for treating a range of cancer types in thousands of studies on laboratory cells, animals, and people. Knowable Magazine

Hence then, the article about why a diabetes drug fell short of anticancer hopes was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Why a Diabetes Drug Fell Short of Anticancer Hopes )

Apple Storegoogle play

Last updated :

Also on site :